{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "10"
        },
        "variant_string_id": "DJ-1 L10P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the DJ-1 gene are causal for autosomal recessive early-onset parkinsonism.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states that DJ-1 mutations cause the disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Protein stability, dimerization, solubility, subcellular localization, and protective function were assessed.",
          "judgment": "Yes",
          "reasoning": "These assays directly evaluate protein function, which is central to the disease mechanism of DJ-1 dysfunction.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Comparisons to wild-type (WT) and L166P DJ-1 variants were made.",
          "judgment": "No",
          "reasoning": "The paper does not explicitly state that multiple replicates were performed or that both positive/negative controls (e.g., null mutants) were used."
        },
        {
          "step_name": "Sub-step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Size-exclusion chromatography, proteasome degradation, and solubility assays were used, which are standard in the field.",
          "judgment": "Yes",
          "reasoning": "The assays are broadly accepted and validate prior findings on DJ-1 pathogenicity.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "Two control variants (WT and L166P) were used across the study.",
          "judgment": "Yes",
          "reasoning": "Only two control variants were used, which is ≤10 total. Functional evidence strength is capped at PS3_supporting.",
          "next_step_or_outcome": "Final strength assigned"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The L10P variant shows reduced protein stability and solubility compared to WT and L166P controls. While the assays are valid, the limited number of controls (≤10) restricts evidence strength to 'supporting'."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "166"
        },
        "variant_string_id": "DJ-1 L166P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the DJ-1 gene are causal for autosomal recessive early-onset parkinsonism.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is explicitly defined."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Protein stability, dimerization, solubility, and proteasome degradation were assessed.",
          "judgment": "Yes",
          "reasoning": "These assays are directly relevant to the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Comparisons to wild-type (WT) and P158DEL variants were made.",
          "judgment": "No",
          "reasoning": "Replicates and comprehensive controls are not explicitly described."
        },
        {
          "step_name": "Sub-step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Size-exclusion chromatography and solubility assays were used, which are standard for DJ-1 studies.",
          "judgment": "Yes",
          "reasoning": "The assays align with prior validation in the field.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "Two control variants (WT and P158DEL) were used across the study.",
          "judgment": "Yes",
          "reasoning": "Only two control variants were used (≤10 total), capping evidence strength at PS3_supporting.",
          "next_step_or_outcome": "Final strength assigned"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The L166P variant exhibits reduced stability and solubility. Limited control variants (≤10 total) restrict evidence strength to 'supporting'."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "P",
          "alt": "DEL",
          "position": "158"
        },
        "variant_string_id": "DJ-1 P158DEL"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the DJ-1 gene are causal for autosomal recessive early-onset parkinsonism.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is explicitly defined."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Protein stability, dimerization, solubility, and proteasome degradation were assessed.",
          "judgment": "Yes",
          "reasoning": "These assays are directly relevant to the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Comparisons to wild-type (WT) and L10P variants were made.",
          "judgment": "No",
          "reasoning": "Replicates and comprehensive controls are not explicitly described."
        },
        {
          "step_name": "Sub-step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Size-exclusion chromatography and solubility assays were used, which are standard for DJ-1 studies.",
          "judgment": "Yes",
          "reasoning": "The assays align with prior validation in the field.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "Two control variants (WT and L10P) were used across the study.",
          "judgment": "Yes",
          "reasoning": "Only two control variants were used (≤10 total), capping evidence strength at PS3_supporting.",
          "next_step_or_outcome": "Final strength assigned"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The P158DEL variant shows reduced stability and solubility. Limited control variants (≤10 total) restrict evidence strength to 'supporting'."
    }
  ]
}